U.S. Pharma Stock News

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...

Star Bulk Carriers recently attracted investor attention after appearing among Zacks.com’s most searched stocks and participating in Capital Link’s online maritime company presentations, where management discussed its business development, strategy, and sector outlook in a live webinar and Q&A. This combination of heightened visibility and a stable earnings outlook, including expectations for significant year-over-year earnings growth, has sharpened focus on how management’s messaging aligns...

Assurant, Inc. reported fourth-quarter 2025 net operating income and revenue above analyst estimates, driven by higher premiums and growth in its Global Housing and Global Lifestyle segments, and outlined 2026 adjusted EBITDA expectations that are consistent with or higher than 2025 alongside continued capital returns to shareholders. Separately, Assurant expanded access to its Reynolds and Reynolds docuPAD eContracting training program and announced that experienced financial services...

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...

EverCommerce (EVCM) has wrapped up FY 2025 with fourth quarter revenue of US$151.2 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$5.7 million. This caps a trailing twelve month period with revenue of US$588.9 million and EPS of US$0.10. Over recent quarters the company has seen revenue range from US$142.3 million to US$151.2 million, with quarterly EPS between US$0.01 and US$0.03. Over the same period, trailing twelve month net income from ongoing...

If you are wondering whether Fiverr International's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock has seen sizeable declines recently, with a 7.7% fall over the last week, a 27.6% decline over the last month, a 46.8% drop year to date, and a 59.2% decline over the past year. This extends a 68.5% and 95.3% fall across the last 3 and 5 years respectively. Recent attention on Fiverr...

SM Energy (NYSE:SM) has agreed to sell a package of Eagle Ford assets for $950 million. The sale forms a major part of the company's $1b divestment program. Proceeds are expected to be used to reduce debt and reshape SM Energy's asset portfolio. For shareholders, this transaction comes with NYSE:SM trading at $26.79 and showing a mixed return profile. The stock is up 3.2% over the past week and 22.3% over the past month, with a 40.0% return year to date, yet it shows a 6.6% decline over the...

If you are wondering whether RH's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are saying about the stock's value today. RH shares last closed at US$128.37, after returns of a 9.7% decline over 7 days, a 35.8% decline over 30 days, a 33.6% decline year to date, a 43.0% decline over 1 year, a 47.9% decline over 3 years and a 75.1% decline over 5 years. Recent coverage around RH has focused on how the company is positioned...

Donaldson Company (NYSE:DCI) has agreed to acquire Facet, a provider of filtration solutions for aerospace, defense, and power generation. The deal is intended to expand Donaldson's product lineup and deepen its presence in durable end markets tied to critical infrastructure and equipment. The acquisition adds exposure to customers that require highly technical filtration in mission critical applications. Donaldson Company focuses on filtration technologies across industrial, engine, and...

Wondering if Dell Technologies at around US$151.62 is still fairly priced, starting to look expensive, or offering value? This article is designed to help you frame that question clearly. The stock has seen strong momentum recently, with returns of 3.5% over 7 days, 22.1% over 30 days, 18.6% year to date, 61.4% over 1 year and 332.1% over 3 years. That naturally raises questions about what is already priced in. Recent coverage has focused on Dell as a key name in large scale computing and...

If you are wondering whether Blue Owl Capital's share price now reflects good value or just fresh risks, you are not alone. This article is here to unpack that question clearly. Over the short term the stock has seen sharp moves, with a 7 day return of an 11.5% decline, a 30 day return of a 30.6% decline and a year to date return of a 42.8% decline, while the 1 year return sits at a 51.8% decline compared to a 6.4% gain over 5 years and a 1.9% decline over 3 years. Recent headlines around...

If you are wondering whether Mohawk Industries at around US$102.55 is a potential bargain or a value trap, you are not alone. The stock has seen a 24.0% decline over the last 30 days and is down 10.3% over the past year, even though the 3 year return sits at 8.7%. Recent headlines have focused on Mohawk Industries' position in the flooring and broader consumer durables market, including how it is responding to shifts in housing activity and renovation demand. This context has kept attention...

Recent share performance and business snapshot Under Armour (UAA) has had a mixed run recently, with the stock down over the past month but positive over the past 3 months. This may prompt investors to reassess the story. The company generated revenue of about US$4.98b and reported a net loss of roughly US$519.71 million, while long term total returns over 3 and 5 years have been negative. This highlights ongoing turnaround questions. See our latest analysis for Under Armour. At a share price...

Event context and recent share performance Hanover Insurance Group (THG) has been on investors’ radar after recent share swings, including a roughly 6% decline over the past 3 months and a small gain over the past month. See our latest analysis for Hanover Insurance Group. At a share price of US$173.39, Hanover Insurance Group’s recent 1 day and 7 day share price declines sit against a modest 1 year total shareholder return of 4.5% and a strong 3 year total shareholder return of 53.4%. This...

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...

In recent weeks, Vital Farms reported weaker-than-expected quarterly earnings, prompting multiple law firms to launch securities investigations while the stock touched a new 52-week low and sector-wide pressures weighed on sentiment. Amid these legal probes and analyst concerns, Director Karl Khoury’s purchase of 5,000 additional shares stands out as a contrasting insider confidence signal. We’ll now examine how the earnings disappointment and resulting legal investigations might reshape...

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...

Earlier this month, Universal Technical Institute reported that it beat its fiscal 2025 operational targets with double‑digit revenue growth while a director, Shannon Lei Okinaka, sold 10,000 shares, about one‑third of her direct holdings, for roughly US$347,414 in an open‑market transaction on March 6, 2026. These developments come as the company is funding an ambitious multi‑year campus expansion that is compressing near‑term profits but is intended to support higher long‑term revenue and...

REX American Resources recently saw its market value reach about US$1.30 billion as its shares moved to fresh highs, ahead of reporting fiscal fourth-quarter and full-year 2025 results on 26 March 2026. This momentum comes even after earlier revenue and earnings declines, as higher oil prices renew attention on REX’s ethanol business as an alternative fuel option. Next, we’ll examine how this oil price-driven momentum in REX’s ethanol operations could influence the company’s existing...

If you are wondering whether Establishment Labs Holdings at around US$63.35 is still offering value or has already run too far, this article is designed to walk you through that question step by step. The share price has seen a 71.0% return over the past year, even though the stock is down 10.0% over the last week, 12.9% over the last month, and 8.0% year to date. This can change how investors think about both its growth potential and risk. Recent news around Establishment Labs has mainly...

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...

Institutional stake cut puts Applied Industrial Technologies in focus Victory Capital Management Inc. recently cut its stake in Applied Industrial Technologies (AIT) by 45.2% in the third quarter, reducing its position to 86,330 shares from 157,638. This move has drawn fresh attention to the stock. See our latest analysis for Applied Industrial Technologies. At a share price of US$255.65, Applied Industrial Technologies has seen a 1 month share price return of 11.94% decline and a year to...

Why SELLAS Life Sciences Group (SLS) Is Back On Traders’ Screens SELLAS Life Sciences Group (SLS) has drawn fresh attention after a sharp move in its share price, with the stock showing a strong gain over the past 3 months and a solid performance over the past month. See our latest analysis for SELLAS Life Sciences Group. At a latest share price of US$5.37, SELLAS Life Sciences Group has paired a 46.32% 30 day share price return with a very large 1 year total shareholder return, hinting that...

Why Hess Midstream (HESM) is back on investor radars Hess Midstream (HESM) is drawing fresh attention after its board authorized a new buyback plan, and the partnership signed a repurchase agreement with JPMorgan to retire up to US$42 million of Class A shares. See our latest analysis for Hess Midstream. At a share price of US$38.99, Hess Midstream has recorded a 7.12% 1 month share price return and 11.94% 3 month share price return. Its 5 year total shareholder return of 166.77% contrasts...